OMJJARA
"OMJJARA" is a word mark owned by GlaxoSmithKline LLC, filed at the IPOS on July 15, 2022. It is registered and covers classes 5, 42 and 44.
- Status
- Registered
- Since July 15, 2022
- Filed
- July 15, 2022
- Registered
- December 27, 2022
- Expires
- July 15, 2032
- Application no.
- 40202252006J
- Registration no.
- 40202252006J
- Office
- IPOS
- Intellectual Property Office of Singapore
- Mark type
- Word mark
- 3 classes
Who owns OMJJARA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
GlaxoSmithKline LLC
United States
Representative
Wong & Leow LLC
Wong & Leow LLC
What the mark covers
The products and services OMJJARA is filed for, grouped by Nice class.
Pharmaceuticals, medical and veterinary preparations; Sanitary preparations for medical purposes; Pharmaceuticals preparations and drugs; Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological preparations for medical purposes; Chemical preparations for medical purposes; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use
Scientific and technological services and research and design relating thereto; Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; Scientific research and development; Scientific laboratory services; laboratory research services; Scientific research for medical purposes; Medical research; Medical laboratory services; conducting clinical trials for others; conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes
Medical services; medical testing services; Medical diagnostic services; Medical evaluation services; Medical examination services; DNA screening and analysis services for medical purposes
What has happened so far
Steps recorded by the IPOS, newest first.
- Request to Change Name, Address and/or Singapore Address for Service for Agent, Applicant/Proprietor and/or other Interested Parties
- Request to Appoint, Change or Remove an Agent
- Request to Appoint, Change or Remove an Agent
- Full Transfer of Ownership
- Request to Change Name, Address and/or Singapore Address for Service for Agent, Applicant/Proprietor and/or other Interested Parties
- Registration procedure completed
- Application filed
About OMJJARA
Who owns the trademark "OMJJARA"?
The IPOS trademark "OMJJARA" (application 40202252006J) is owned by GlaxoSmithKline LLC.
What is the status of "OMJJARA"?
Its status at the IPOS is: registered.
When was "OMJJARA" registered?
It was registered on December 27, 2022 and is due to expire on July 15, 2032.
Get this data via the API
Everything on this page comes from the Signa API. Pull OMJJARA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019df678-4e08-72db-95a4-24ed4205edb3
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019df678-4e08-72db-95a4-24ed4205edb3",
"object": "trademark",
"mark_text": "OMJJARA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "SG",
"application_number": "40202252006J",
"filing_date": "2022-07-15",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "GlaxoSmithKline LLC",
"entity_id": "ent_019ebbad-4be6-7544-bafb-06b4c2a2ecb2"
}
]
}